Cargando…

CHEK2 Alterations in Pediatric Malignancy: A Single-Institution Experience

SIMPLE SUMMARY: Pediatric malignancies rarely occur, with 12,000–15,000 cases per year in the United States. Approximately 10% of pediatric cancers are thought to be secondary to germline alterations in cancer-predisposing genes based on numerous germline genomic analyses. CHEK2 germline loss-of-fun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelghani, Eman, Schieffer, Kathleen M., Cottrell, Catherine E., Audino, Anthony, Zajo, Kristin, Shah, Nilay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046043/ https://www.ncbi.nlm.nih.gov/pubmed/36980535 http://dx.doi.org/10.3390/cancers15061649

Ejemplares similares

CHEK2 mutations in pediatric brain tumors
por: Tlais, Dana, et al.
Publicado: (2023)

LGG-14. TREATMENT OF TWO PEDIATRIC FGFR-ALTERED LOW-GRADE GLIONEURONAL TUMORS WITH MEK INHIBITION
por: Lazow, Margot, et al.
Publicado: (2023)

Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors
por: Fadaka, Adewale Oluwaseun, et al.
Publicado: (2020)

The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study
por: Alorjani, Mohammed, et al.
Publicado: (2023)

Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast Cancer
por: Lin, Wei-Yu, et al.
Publicado: (2013)

Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2
por: Bychkovsky, Brittany L., et al.
Publicado: (2022)

Checkpoint Kinase 2 (CHEK2) Mutation in Renal Cell Carcinoma: A Single-Center Experience
por: Huszno, Joanna, et al.
Publicado: (2018)

The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
por: Mandelker, Diana, et al.
Publicado: (2019)

Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006)

Clinical response to dabrafenib plus trametinib in a pediatric ganglioglioma with BRAF p.T599dup mutation
por: Miller, Katherine E., et al.
Publicado: (2021)

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2021)

Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population
por: Wang, Shijia, et al.
Publicado: (2018)

Clinical performance of the H. PYLORI QUIK CHEK™ and H. PYLORI CHEK™ assays, novel stool antigen tests for diagnosis of Helicobacter pylori
por: Halland, Magnus, et al.
Publicado: (2021)

CHEK2 variants associate with hereditary prostate cancer
por: Seppälä, E H, et al.
Publicado: (2003)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

Prevalence of the CHEK2 R95* germline mutation
por: Knappskog, Stian, et al.
Publicado: (2016)

Current perspectives on CHEK2 mutations in breast cancer
por: Apostolou, Panagiotis, et al.
Publicado: (2017)

CHEK2 Pathogenic Germline Variants in Patients With NSCLC
por: Sorscher, Steven
Publicado: (2022)

Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement
por: Miller, Katherine E., et al.
Publicado: (2022)

Pediatric glioblastoma multiforme: A single-institution experience
por: Ansari, Mansour, et al.
Publicado: (2012)

Effects of the COVID-19 pandemic on the pediatric emergency department: a single institution experience
por: Masler, Isabella V., et al.
Publicado: (2022)

Evolutionary analysis of the highly dynamic CHEK2 duplicon in anthropoids
por: Münch, Claudia, et al.
Publicado: (2008)

In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2
por: Kim, S, et al.
Publicado: (2008)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Clinical relevance of CHEK2 and NBN mutations in the macedonian population
por: Kostovska, I Maleva, et al.
Publicado: (2015)

Survival of bladder or renal cancer in patients with CHEK2 mutations
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
por: Koen, Kortbeek, et al.
Publicado: (2022)

Recurrent Acromegaly in a Patient With a CHEK2 Mutation
por: Perosevic, Milica, et al.
Publicado: (2021)

Multiple Primary Melanoma in a CHEK2 Mutation Carrier
por: Álvarez-Salafranca, Marcial, et al.
Publicado: (2023)

Malignant adnexal tumors of the skin: a single institution experience
por: Oyasiji, Tolutope, et al.
Publicado: (2018)

Tumors of low malignant potential a single institution experience
por: Jbir, Ichraf, et al.
Publicado: (2019)

Cutaneous metastases of internal malignancies: a single‐institution experience
por: Vernemmen, Astrid I P, et al.
Publicado: (2022)

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
por: Stolarova, Lenka, et al.
Publicado: (2023)

Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures
por: Ow, Ghim Siong, et al.
Publicado: (2014)

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)

CHEK2 contribution to hereditary breast cancer in non-BRCA families
por: Desrichard, Alexis, et al.
Publicado: (2011)

CHEK2 (∗)1100delC Mutation and Risk of Prostate Cancer
por: Hale, Victoria, et al.
Publicado: (2014)

Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
por: Xie, Changqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6bv4omm3t6g4lhuls9jj8s5acm